Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK715m

    Last close

    SEK13.80

    ▲ −0.30 (−2.13%)

    VolitionRx

    MCap

    USD56m

    Last close

    USD0.60

    ▲ 0.00 (−0.66%)

    Portobello SpA

    MCap

    EUR16m

    Last close

    EUR2.90

    ▲ 0.52 (21.85%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Evolva – EKF interview

Evolva – EKF interview

Evolva — 2 videos in collection

More on this equity

Evolva is a Swiss biotech company focused on the research, development and commercialisation of ingredients based on nature. It has leading businesses in Flavours and Fragrances, Health Ingredients and Health Protection. Evolva’s proprietary fermentation-based technology allows for the large-scale production of ingredients that would otherwise be prohibitively expensive. It recently obtained US EPA registration of its nootkatone product for use in pest control, which opens up a significant market.

See more at:

< Previous
Next >

You may also be interested in these:

Consumer

Evolva - EKF interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free